A randomised clinical trial to evaluate a digital therapeutic (TH-001) for improving glycaemic control in adults with prediabetes
TH-001 demonstrates significant effectiveness in HbA1c reduction and body weight, with strong user engagement suggesting it may effectively overcome traditional barriers of DPPs. Long-term studies are needed to confirm sustained benefits.Efficacy and Safety of Digital Therapeutic in Adults with Prediabetes; https://clinicaltrials.gov/study/NCT05668819; ClinicalTrials.gov ID: NCT05668819.
Authors
- Kamal S. Saini (ORCID: https://orcid.org/0000-0001-6301-3309)
- Özer Akgül (ORCID: https://orcid.org/0000-0002-3802-3270)
- Ramazan Çakmak (ORCID: https://orcid.org/0000-0003-3815-7444)
- Orkide Kutlu (ORCID: https://orcid.org/0000-0002-4402-2231)
- İlker Tosun (ORCID: https://orcid.org/0000-0002-3710-4706)
- Jennifer Carnell
- Hasan Avcu (ORCID: https://orcid.org/0009-0003-0597-5173)
- Gürkan Caner Birer (ORCID: https://orcid.org/0000-0001-7236-5613)
Institutions
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Cambridge University Health Partners (GB)
- Istinye University (TR)
- Istanbul Eye Hospital (TR)
- Addenbrooke's Hospital (GB)
- Istanbul Health and Technology University
- Istanbul Technical University (TR)
- Cardiff University (GB)
Publication Details
- Journal
- Digital Health
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1177/20552076251376260
- Primary Topic
- Diabetes Management and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00